Location History:
- Berkshire, GB (2004 - 2011)
- London, GB (1998 - 2022)
Company Filing History:
5 out of 8 
4 out of 11 
2 out of 13 
Years Active: 1998-2022
Title: The Innovations of Gordon Dougan
Introduction
Gordon Dougan, an esteemed inventor based in London, GB, has made significant contributions to the field of microbiology through his innovative work. With an impressive portfolio of 18 patents, Dougan has focused his research on methods for identifying bacterial isolates, particularly in the context of bacteriotherapy. His pioneering approaches have paved the way for advancements in understanding and utilizing beneficial bacteria for health purposes.
Latest Patents
Among Dougan's latest patents are two notable innovations:
1. **Method for the Identification of Bacteria**: This method involves a series of steps designed for the identification of bacterial isolates suitable for use in bacteriotherapy. It includes:
(i) preparing a suspension of material collected from a host harboring microbiota;
(ii) addition of an activator of bacterial spores sufficient to allow growth of bacteria from spores present in the suspension;
(iii) culturing the suspension; and
(iv) identification of at least one bacterial species within the culture.
2. **Method for Identifying Bacteria for Bacteriotherapy**: Similar to the previous patent, this method encompasses a structured process aimed at identifying bacterial isolates for bacteriotherapy. It repeats the critical steps of preparing a suspension, adding an activator, culturing, and then identifying specific bacterial species.
Career Highlights
Gordon Dougan's career has been marked by notable positions at esteemed companies such as Emergent Product Development UK Limited and Microscience Limited. His extensive experience in these organizations has enabled him to contribute to cutting-edge research and development in microbiology and bacteriology. Dougan's work continues to showcase his commitment to advancing health sciences through innovation.
Collaborations
Throughout his career, Dougan has collaborated with esteemed colleagues, including Robert Graham Feldman and Joseph David Santangelo. Their collective expertise has undoubtedly enriched the field of microbiology, contributing to significant research and developments in bacterial therapy.
Conclusion
Gordon Dougan stands out as a prominent inventor whose work has greatly impacted the field of bacteriology. With 18 patents to his name, his innovative methods for identifying bacteria suitable for bacteriotherapy are paving the way for future research and applications. His collaborations and career achievements exemplify the important role inventors play in shaping medical advancements and improving our understanding of microbiota.